Amgen Exercises Option For Exclusive License To Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 (PharmaceuticalOnline)
Cytokinetics Incorporated (Nasdaq: CYTK) and Amgen Inc. (Nasdaq: AMGN) today announced that Amgen has exercised its option to obtain an exclusive license, worldwide (excluding Japan), to Cytokinetics' cardiac contractility program.

KCI Announces FDA Clearance Of ABThera Open Abdomen Dressing (Medical News Today)
Kinetic Concepts, Inc. (NYSE: KCI) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ABThera Open Abdomen Dressing. Earlier this year, the FDA cleared the ABThera Open Abdomen Negative Pressure Therapy Unit.